# Jasper Therapeutics, Inc.: Form SC 13D, filed Oct 4, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: SC 13D
- Filed: 2021-10-04
- Accepted by EDGAR: Oct 4, 2021, 16:10 ET
- Period: not reported
- Accession: 0000905718-21-001266
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000090571821001266/jasper_13dsep242021.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000090571821001266/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000090571821001266/jasper_13dsep242021.htm

Filed Oct 4, 2021.
Source: SEC EDGAR, the filing index for accession 0000905718-21-001266. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
